Back
Guidewire Software, Inc. Vs. Stoke Therapeutics, Inc. Industry Stock Comparison
Buy
57
GWRE
Guidewire Software, Inc.
Last Price:
$204.62
Seasonality Move:
3.7%
Buy
68
STOK
Stoke Therapeutics, Inc.
Last Price:
$33.08
Seasonality Move:
1.4%
Buy
57
Guidewire Software, Inc. (GWRE)
is a Buy
Is Guidewire Software, Inc. a Buy, Sell or Hold?
-
The current Guidewire Software, Inc. [GWRE] share price is $204.54. The Score for GWRE is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
GWRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Stoke Therapeutics, Inc. (STOK)
is a Buy
Is Stoke Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Stoke Therapeutics, Inc. [STOK] share price is $33.09. The Score for STOK is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
STOK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GWRE Stock Price Chart
What is Guidewire Software, Inc.'s stock price today?
-
The Guidewire Software, Inc. share price today is $204.54Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GWRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
STOK Stock Price Chart
What is Stoke Therapeutics, Inc.'s stock price today?
-
The Stoke Therapeutics, Inc. share price today is $33.09Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing selling pressure, which indicates risk of future bearish movement.
GWRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.47 | Sell |
| Relative Strength Index (14 RSI): | 37.96 | Sell |
| Chaikin Money Flow: | 811623 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (206.71 - 219.21) | Sell |
| Bollinger Bands (100): | (211.63 - 242.65) | Sell |
STOK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.29 | Buy |
| Relative Strength Index (14 RSI): | 60.05 | Buy |
| Chaikin Money Flow: | -924088 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.5 - 31.94) | Buy |
| Bollinger Bands (100): | (17.56 - 30.8) | Buy |
GWRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 206.83 | Sell |
| 20-day SMA: | 211.61 | Sell |
| 50-day SMA: | 226.2 | Sell |
| 200-day SMA: | 218.82 | Sell |
| 8-day EMA: | 205.56 | Sell |
| 20-day EMA: | 211.68 | Sell |
| 50-day EMA: | 220.7 | Sell |
| 200-day EMA: | 216.15 | Sell |
STOK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.68 | Buy |
| 20-day SMA: | 30 | Buy |
| 50-day SMA: | 29.59 | Buy |
| 200-day SMA: | 16.86 | Buy |
| 8-day EMA: | 31.92 | Buy |
| 20-day EMA: | 30.46 | Buy |
| 50-day EMA: | 28.38 | Buy |
| 200-day EMA: | 20.14 | Buy |
Guidewire Software, Inc. Earnings Growth & GWRE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.11 per share, an increase this year of $1.12 per share, and an increase next year of $0.58 per share.
Stoke Therapeutics, Inc. Earnings Growth & STOK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.07 per share, and a decrease next year of $3.13 per share.
Guidewire Software, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Stoke Therapeutics, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||